CPI-0610, A BROMODOMAIN AND EXTRATERMINAL DOMAIN (BET) PROTEIN INHIBITOR, IN COMBINATION WITH RUXOLITINIB, IN JAK INHIBITOR-NAIVE MYELOFIBROSIS PATIENTS: UPDATE OF MANIFEST PHASE 2 STUDY

Palandri F., Mascarenhas J., Harrison C., Patriarca A., Devos T., Rampal R., Vannucchi A., Passamonti F., Mead A., Kremyanskaya M., Somervaille T., Wondergem M., Hoffman R., Luptakova K., Wang J., Colak G., Shao J., Bobba S., Trojer P., Verstovsek S., Gupta V., Investigators MANIFEST.

Type

Conference paper

Publication Date

10/2021

Volume

106

Pages

5 - 6

Permalink